Anti-doping comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Common internet and media name. |
| Research code | GW501516 | Also written GW-1516. |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator. |
| Development status | Discontinued | Clinical development halted after rodent cancer findings. |
| Regulatory status | Prohibited in sport | Listed by WADA; not approved as medicine. |
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
== Guinea == Karamokho Alfa – Religious leader who led a jihad that led to the formation of Futa Jallon, Guinea Ibrahim Sori Mawdo (The Elder) – Religious leader and Second Almaami of Futa Jalon, Guinea Abdul Rahman Ibrahima Sori - was a Fulani prince and Amir, from Fouta Djallon, in modern-day Guinea, West Africa, who was captured and sold to European slave traders, causing him to be enslaved in Mississippi, U.S, for 40 years. Bokar Biro – last independent Almamy of Fuuta Jalon, Resistance hero to French invasion, Guinea Thierno Aliou – Author, Muslim theologian and politician, Guinea Yacine Diallo – Politician. former member of French National Assembly, Guinea Boubacar Diallo Telli – Diplomat and politician. First Secretary-General of the Organization of African Unity (OAU), UN Representative, Ambassador to USA, Minister of Justice, Guinea Binta Pilote - Guinea armed forces pilot, first black female helicopter pilot in Africa. Aminata Diallo (military) - Second Brigadier-General Guinea Armed forces. Amadou Oury Bah (In French) - Prime Minister Guinea Saifoulaye Diallo - former foreign minister, former president of the National Assembly. Aïcha Bah Diallo - former Guinean education minister and women's rights activist. Mariama Wax Sylla (in french) - Former World Bank Group Resident Representative for Namibia, former minister of Agriculture, Minister of the Economy, Finance and Budget, Guinea.
The Annals of Clinical & Laboratory Science is a quarterly academic journal. It is the official journal of, and is published by, the Association of Clinical Scientists. It was established in 1971 as Annals of Clinical Laboratory Science by F. William Sunderman and obtained its current title in 1973. As of 2022, the editor-in-chief is Nina Tatevian.
The primary antihypertensive mechanism of beta blockers is unclear, but may involve reduction in cardiac output (due to negative chronotropic and inotropic effects). It may also be due to reduction in renin release from the kidneys, and a central nervous system effect to reduce sympathetic activity (for those beta blockers that do cross the blood–brain barrier, e.g. propranolol). Antianginal effects result from negative chronotropic and inotropic effects, which decrease cardiac workload and oxygen demand. Negative chronotropic properties of beta blockers allow the lifesaving property of heart rate control. Beta blockers are readily titrated to optimal rate control in many pathologic states. The antiarrhythmic effects of beta blockers arise from sympathetic nervous system blockade—resulting in depression of sinus node function and atrioventricular node conduction, and prolonged atrial refractory periods. Sotalol, in particular, has additional antiarrhythmic properties and prolongs action potential duration through potassium channel blockade. Blockade of the sympathetic nervous system on renin release leads to reduced aldosterone via the renin–angiotensin–aldosterone system, with a resultant decrease in blood pressure due to decreased sodium and water retention.
== Prognosis == Due to the high rates of recurrence following initial therapy and the short overall survival times of individuals with BPDCN, prognosis of the disease is poor. However, further study of treatment regimens that include intrathecal chemotherapy and hematological stem cell transplantation in initial treatment regimens (see previous section) and newer non-chemotherapeutic drug treatments (see next section) may improve this situation.
==== Public opinion on impeachment ==== In a survey conducted by Economist/YouGov, half of the American public (50%) expressed strong or somewhat support for the impeachment of Defense Secretary Pete Hegseth, citing his decision to initiate military action against Iran without congressional authorization. Roughly three in ten Americans (30%) indicated opposition to such a move. This sentiment, however, is far from uniform across the political spectrum. Democrats demonstrated the highest level of support for impeachment, with 77% in favor and only 14% opposed. Independents also leaned toward impeachment, with 50% in support and 22% against. Republicans, by contrast, largely rejected the idea, opposing impeachment by a margin of 53% to 26%.
Sources: en.wikipedia.org
=== Pharmacokinetics === The oral bioavailability of oxandrolone is 97%. Its plasma protein binding is 94 to 97%. The drug is metabolized primarily by the kidneys and to a lesser extent by the liver. Oxandrolone is the only AAS that is not primarily or extensively metabolized by the liver, and this is thought to be related to its diminished hepatotoxicity relative to other AASs. Its elimination half-life is reported as 9.4 to 10.4 hours, but is extended to 13.3 hours in the elderly. About 28% of an oral dose of oxandrolone is eliminated unchanged in the urine and 3% is excreted in the feces.
RNA-eIF4E complexes are never observed in PML bodies consistent with the observation that PML suppresses the m7G cap binding function of eIF4E. Structural studies show that a related arenavirus RING finger protein, Lassa Fever Z protein, can similarly bind eIF4E on the dorsal surface. eIF4E nuclear entry is mediated by its direct interactions with Importin 8 where Importin 8 associates with the m7G cap-binding site of eIF4E. Indeed, reduction in Importin 8 levels reduce the oncogenic potential of eIF4E overexpressing cells and its RNA export function. Importin 8 binds to the cap-binding site of eIF4E and is competed by excess m7G cap analogues as observed by NMR. eIF4E also stimulates the RNA export of Importin 8 RNA thereby producing more Importin 8 protein. There may be additional importins that play this role depending on cell type. Although an initial study suggested that the eIF4E transporter protein 4E-T (eIF4ENIF1) facilitated nuclear entry, later studies showed that this factor rather alters the localization of eIF4E to cytoplasmic processing bodies (P-bodies) and repress translation. Potyvirus viral protein genome linked (VPg) were found to directly bind eIF4E in its cap-binding site. VPg is covalently linked to its genomic RNA and this interaction allows VPg to act as a "cap." The potyvirus VPg has no sequence or structural homology to other VPg's such as those from poliovirus.
Through pilot project funding, multidisciplinary mentorship, educational seminars, career development programs, and collaborative research opportunities, the Center provides early-stage investigators with the resources necessary to establish independent research programs. Junior faculty benefit from access to experienced mentors across multiple disciplines, specialized research cores, and opportunities to participate in multicenter studies and national collaborations. These efforts are closely integrated with the Barshop Institute's NIH-funded Biology of Aging Training Program (T32), creating a comprehensive environment for training predoctoral students, postdoctoral fellows, clinical fellows, and junior faculty in translational geroscience and geriatrics.
== Size exclusion chromatography == Prior to these studies, HPLC analyses were tuned by modifying the mobile and stationary phases only. Gradient elution for HPLC merely meant changing the ratio of solvents to improve column efficiency, and this requires the use of sophisticated solvent pumping mechanisms along with extra steps and precautions in the chromatographic analysis. Enlightened by the prospect of using temperature gradient elutions for HPLC analyses, Hosoya et al. sought to make surface modification of HPLC stationary phases more accessible. Their study utilizes graft-type copolymerization of PNIPAAm onto macroporous polymeric materials. The in-situ preparation compared the use of cyclohexanol and toluene as porogens in the preparation of the modified polystyrene seeds. Reverse-phased size-exclusion chromatography (SEC) revealed pore size and pore size distribution of the particles and its dependence on temperature. Cyclohexanol acted as a successful porogen showing a dependent relationship of pore size to temperature. The use of toluene as a porogen gave results that were similar to unmodified macroporous particles. This indicates that PNIPAAm can be successfully grafted onto the surface and within the pores of macroporous materials. The application of this preparatory technique gives rise to tunable pore sizes. Temperature gradient elutions can be used to improve column efficiency through the changing of pore size in SEC.
Sources: en.wikipedia.org
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.
Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.
No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.